China's "Walking Pneumonia" Outbreak: WHO Demands Transparency

China is currently facing a major outbreak of mycoplasma infections, particularly affecting children, leading to overcrowded hospitals and extended waiting times for medical attention. The surge in cases is attributed to an "immunity gap" in children due to strict lockdown measures implemented during the COVID-19 pandemic, resulting in lower immunity and higher susceptibility to infection. Antibiotic resistance is also a concern, as overuse and misuse of antibiotics in China have contributed to the emergence of antibiotic-resistant strains of mycoplasma pneumonia. The true extent of the outbreak may be underestimated due to underreporting and underdiagnosis. The World Health Organization advises following normal respiratory illness prevention measures, including vaccination and isolation if symptoms emerge.
- Explainer: Why China is facing major outbreak of ‘Walking pneumonia’ epidemic IndiaTimes
- WHO pressing China for details on spike in cases of new virus ABC News
- China's pneumonia scare: Transparency please | Mint Mint
- China's "Walking Pneumonia" Outbreak Worsens: Thousands Hospitalised | Vantage with Palki Sharma Firstpost
- Respiratory virus in China not thought to be novel pathogen, officials say Axios
Reading Insights
0
11
3 min
vs 4 min read
85%
755 → 112 words
Want the full story? Read the original article
Read on IndiaTimes